Electronic Drug Delivery Systems Market
完整報告名稱與涵蓋範圍
Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Wearable Infusion Pumps, Auto Injectors, Injection Pens, and Inhalers), By Application (Diabetes, Cardiovascular Disease (CVD), Respiratory Disorders, Multiple Sclerosis ), By Distribution Channel, By Region, And Segment Forecasts, 2024-2031
報告摘要
A CAGR of 7.06% is forecasted for the global Electronic Drug Delivery Systems Market over the assessment period of 2024 through 2031.
Electronic Drug Delivery Systems covers particularly well adapted to home care settings. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Electronic Drug Delivery Systems Market Snapshot
Chapter 4. Global Electronic Drug Delivery Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Wearable Infusion Pumps
5.2.2. Auto Injectors
5.2.3. Injection Pens
5.2.4. Inhalers
Chapter 6. Market Segmentation 2: by Distribution Channel Estimates & Trend Analysis
6.1. by Distribution Channel & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Diabetes
7.2.2. Cardiovascular Disease (CVD)
7.2.3. Respiratory Disorders
7.2.4. Multiple Sclerosis
7.2.5. Others
Chapter 8. Electronic Drug Delivery Systems Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.1.3. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.4. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.2.3. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.3.3. Asia-Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Asia Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.4.3. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.5.3. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Bayer AG
9.2.2. Gerresheimer AG
9.2.3. Medtronic
9.2.4. Elcam Medical
9.2.5. Novo Nordisk A/S
9.2.6. Insulet Corporation
9.2.7. BD
9.2.8. Sanofi
9.2.9. Frederick Furness Publishing
9.2.10. United Therapeutics Corporation
9.2.11. AstraZeneca
9.2.12. Tandem Diabetes Care
9.2.13. Merck Group Amgen
9.2.14. United Therapeutics Corporation
9.2.15. F. Hoffmann-La Roche
9.2.16. Companion Medical
9.2.17. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們